CSIMarket
 


Immuron Limited  (IMRN)
Other Ticker:  
 

Cumulative Immuron Limited's Leverage Ratio for Trailing Twelve Months Period

IMRN's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

IMRN Leverage Ratio for Trailing Twelve Months Period

(Jun 30 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2020)
IV. Quarter
Y / Y Equity Growth 358.81 % 358.81 % 358.81 % 358.81 % -23.22 %
Y / Y Total Liabilities Growth 107.44 % 107.44 % 107.44 % 107.44 % -53.88 %
Leverage Ratio for Trailing Twelve Months Period 0.04 0.05 0.05 0.07 0.1
Total Ranking # 90 # # # # 92
Seq. Equity Growth 0 % 0 % 0 % 358.81 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % 107.44 % 0 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of 0% Immuron Limited decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 0.04, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 28 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Immuron Limited. While Leverage Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 90.

What is Leverage Ratio?
Who are IMRN's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 29
Sector # 34
S&P 500 # 90


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.16 0.09 0.04
(Jun 30 2019)   (Jun 30 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2021, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Benitec Biopharma Inc   0.12 
Bolt Biotherapeutics Inc   0.12 
Immutep Limited  0.12 
Kiniksa Pharmaceuticals Ltd   0.12 
Viracta Therapeutics Inc   0.12 
Advaxis Inc.  0.12 
Generation Bio Co   0.12 
Pfenex Inc   0.12 
Enlivex Therapeutics Ltd   0.12 
Immunic Inc   0.11 
Akouos inc   0.11 
Deciphera Pharmaceuticals Inc   0.11 
Sio Gene Therapies Inc   0.11 
Allakos Inc   0.11 
Y mabs Therapeutics inc   0.11 
Processa Pharmaceuticals Inc   0.11 
Tyme Technologies Inc.  0.11 
Cara Therapeutics inc   0.11 
Marizyme Inc   0.11 
Iveric Bio Inc   0.11 
Landos Biopharma Inc   0.10 
Kronos Bio Inc   0.10 
Rapt Therapeutics Inc   0.10 
Cellectar Biosciences Inc   0.10 
Akcea Therapeutics Inc   0.10 
Citius Pharmaceuticals Inc   0.10 
Phio Pharmaceuticals Corp   0.10 
Centessa Pharmaceuticals Plc  0.10 
Myokardia Inc   0.10 
Magenta Therapeutics Inc   0.10 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALCO's Profile

Stock Price

ALCO's Financials

Business Description

Fundamentals

Charts & Quotes

ALCO's News

Suppliers

ALCO's Competitors

Customers & Markets

Economic Indicators

ALCO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071